Structure Therapeutics
GPCR · NASDAQ
$22.88+$0.87 (+3.95%)TodayMarket closed ·
Prev close $22.01
EPS: actual vs estimate
Beat the estimate in 1 of the last 8 quarters, by 1.2% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.4056 | -$0.49 | −20.8% |
| Q1 FY26 | -$0.3543 | -$0.35 | +1.2% |
| Q4 FY25 | -$0.4746 | -$1.22 | −157.1% |
| Q3 FY25 | -$0.3584 | -$1.11 | −209.7% |
| Q2 FY25 | -$0.2813 | -$1.08 | −283.9% |
| Q1 FY25 | -$0.2335 | -$0.81 | −246.9% |
| Q4 FY24 | -$0.2283 | -$0.69 | −202.2% |
| Q3 FY24 | -$0.1896 | -$0.60 | −216.5% |
Earnings calls
- Morgan Stanley 24th Annual Global Healthcare Conference
- Special Call - Structure Therapeutics Inc.
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Special Call - Structure Therapeutics Inc.
- Special Call - Structure Therapeutics Inc.
- Morgan Stanley 23rd Annual Global Healthcare Conference
- Goldman Sachs 46th Annual Global Healthcare Conference 2025
- Special Call - Structure Therapeutics Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.